| abstract |
The present invention relates to medicaments and uses, and in particular to methods of treating specific clinical conditions such as hyperglycemia, type 2 diabetes, arthritis and multiple sclerosis. The invention also provides methods of identifying and characterizing drugs characterized in part by eliciting distinct biological therapeutic effects on biomolecules at one time and relative normalization of the biomolecules at another time point. Said compounds include 17α-ethynylandrost-5-ene-3β,7β,17β-triol or androst-5-ene-3β,4β,16α,17β-tetrol, which can be used as reference standards to facilitate Evaluation and characterization of this drug candidate. |